The endocannabinoid system and the brain.
The DOI matches its Crossref record; 181 of the 182 references it cites were found in a registry or an index.
Abstract
The psychoactive constituent in cannabis, Δ 9 -tetrahydrocannabinol (THC), was isolated in the mid-1960s, but the cannabinoid receptors, CB1 and CB2, and the major endogenous cannabinoids (anandamide and 2-arachidonoyl glycerol) were identified only 20 to 25 years later. The cannabinoid system affects both central nervous system (CNS) and peripheral processes. In this review, we have tried to summarize research—with an emphasis on recent publications—on the actions of the endocannabinoid system on anxiety, depression, neurogenesis, reward, cognition, learning, and memory. The effects are at times biphasic—lower doses causing effects opposite to those seen at high doses. Recently, numerous endocannabinoid-like compounds have been identified in the brain. Only a few have been investigated for their CNS activity, and future investigations on their action may throw light on a wide spectrum of brain functions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Many of the neural and behavioral effects of exogenously administered cannabinoids can be traced directly to activation of the `endocannabinoid' (ECB) system [10]”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [10]
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633 · cited 2×
“Indeed, we were able to isolate and identify two compounds, one from brain— which we named anandamide, based on the Sanskrit word ananda (“supreme joy”)—and a second one [2-arachidonoyl glycerol (2-AG)] from peripheral tissues (Devane et al. 1992, Mechoulam et al. 1995).”
BackgroundSelf-citationMolecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · cited 2×
“…Relapse . . . . . . . . . . 6.11 CANNABINOIDS AND COGNITION . . . . . . . . . . . . . . . . . . . . 6.13 Effects of Cannabis on Cognition in Humans . . . . . . . . . . . . . . . . . . . . . . . . 6.13 Effects of CB1 Agonists on Learning and Memory in Nonhumans . . . . . 6.14 Effects of CB1…”
BackgroundInfluentialStructure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011 · cited 3×
“Their distribution was found to be consistent with the pharmacological properties of psychotropic cannabinoids (Herkenham et al. 1990), and the receptor was cloned (Matsuda et al. 1990).”
BackgroundInfluentialNeural systems of reinforcement for drug addiction: from actions to habits to compulsion
Everitt, B. J., & Robbins, T. W. (2005) · Nature Neuroscience · doi:10.1038/nn1579 · Cited by 3,785 · cited 1×
“Relapse is characterized by drug-seeking behavior in extinction triggered by renewed exposure to drug-associated cues or a priming dose of a drug itself (Everitt & Robbins 2005).”
BackgroundMechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913 · cited 1×
“It seems possible that the CB2 receptor is part of a general protective system (for a review, see Pacher & Mechoulam 2011).”
BackgroundSelf-citationInternational Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819 · cited 5×
“Both receptor types are coupled through G proteins to adenylyl cyclase and mitogen-activated protein kinase (for a detailed review on the pharmacology of cannabinoids, see Howlett et al. 2002).”
BackgroundInfluentialSelf-citationDetermination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443 · cited 2×
“The same group shortly thereafter indeed reported the existence of binding sites in the brain (Devane et al. 1988).”
BackgroundInfluentialIsolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,393 · cited 2×
“With the advance of modern separation techniques, the isolation and the structure elucidation of the active principle, THC, was finally achieved in 1964 (Gaoni & Mechoulam 1964).”
BackgroundSelf-citationCannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321 · cited 2×
“Their distribution was found to be consistent with the pharmacological properties of psychotropic cannabinoids (Herkenham et al. 1990), and the receptor was cloned (Matsuda et al. 1990).”
BackgroundInfluentialThe Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077 · cited 2×
“There is emerging evidence that lipid endocannabinoid signaling through CB2 receptors may represent an example/part of such a protective system” (Pacher & Mechoulam 2011, p. 194).”
Background
Research works printed but not linked: 3
- Da Orta G, Cannabis: A History., 1563
- 10.1177/0269881104047277 · doi:10.1177/0269881104047277 · Paper page
- Zanettini C, 2012, Front. Behav. Neurosci., 5, 57
Cited by
Adverse health effects of marijuana use.
Volkow, N. D., Baler, R. D., Compton, W. M., & Weiss, S. R. B. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1402309 · Cited by 2,774
Endocannabinoid Signaling and Synaptic Function
Castillo, P. E., Younts, T. J., Chávez, A. E., & Hashimotodani, Y. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.020 · Cited by 1,120
“Moreover, dysregulation of the eCB system is implicated in neuropsychiatric conditions such as depression and anxiety (Hillard et al., 2012; Mechoulam and Parker, 2012).”
BackgroundSynthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications
Castaneto, M. S., Gorelick, D. A., Desrosiers, N. A., Hartman, R. L., Pirard, S., & Huestis, M. A. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.08.005 · Cited by 709
“CB1 agonist activation down regulates adenylyl cyclase and decreases cellular cAMP levels, which triggers a cascade of reactions that affects cellular signaling and neurotransmitter inhibition, including acetylcholine, dopamine, noradrenaline, and glutamine, and γ-aminobutyric acid (GABA) (Mechoulam and Parker, 2013;…”
BackgroundInfluentialAcute and Chronic Effects of Cannabinoids on Human Cognition—A Systematic Review
Broyd, S. J., van Hell, H. H., Beale, C., Yücel, M., & Solowij, N. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.12.002 · Cited by 674
Neurobiological Interactions Between Stress and the Endocannabinoid System
Morena, M., Patel, S., Bains, J. S., & Hill, M. N. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.166 · Cited by 660
“The eCB system nomenclature derives from the finding that eCBs and plant-derived cannabinoids converge on a common molecular receptor target (Mechoulam and Parker, 2013).”
Background
Metadata
- Authors
- Mechoulam, R., & Parker, L. A.
- Affiliations
- Hebrew University of Jerusalem (IL)
- University of Guelph (CA)
- Venue
- Annual Review of Psychology
- Publisher
- Annual Reviews
- Published
- 2013-01-03
- Volume
- 64
- Issue
- 1
- Pages
- 21-47
- ISSN
- 0066-4308 (ISSN-L)
- 1545-2085
- OpenAlex
- W2097747770
- Cited by
- 1,090
- References
- 182
- Citations by year
- 2026: 51 · 2025: 68 · 2024: 68 · 2023: 83 · 2022: 103 · 2021: 107 · 2020: 122 · 2019: 81 · 2018: 97 · 2017: 59 · 2016: 73 · 2015: 63 · 2014: 65 · 2013: 41
- FWCI
- 6.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Psychology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Natural Sciences and Engineering Research Council of Canada
- National Institutes of Natural Sciences
- National Institute of Mental Health
- National Institute on Drug Abuse (P01DA009789, DA-9789)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Keywords
- endocannabinoid system, cannabinoid receptors, CB1 receptor, CB2 receptor, anandamide, 2-arachidonoylglycerol, delta-9-tetrahydrocannabinol, anxiety, depression, neurogenesis, reward, cognition, learning and memory
- MeSH terms
- Animals, Anxiety Disorders, Brain, Cannabinoids, Cannabis, Cognition, Depressive Disorder, Dose-Response Relationship, Drug, Humans, Learning, Memory, Reward, Dronabinol, Receptors, Cannabinoid, Neurogenesis, Endocannabinoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The endocannabinoid system and the brain. https://app.cochat.ai/papers/10.1146/annurev-psych-113011-143739
- The paper
- Mechoulam, R., & Parker, L. A. (2013). The endocannabinoid system and the brain. Annual Review of Psychology. https://doi.org/10.1146/annurev-psych-113011-143739
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.